Etiometry Does a Double Take – Expands Client Base Twofold in One Year
News and Press Releases
BOSTON, December 18, 2018 – From Omaha to Pakistan, Etiometry has doubled their client base in the last year. These new partnerships are placing the Etiometry Platform beside hundreds of beds, and empowering clinicians to make data-driven decisions on more than tens of thousands of patients per year. “Every partnership is a chance to improve countless outcomes for patients at the most critical point in their care. We are honored to work with the top academic medical centers in the world and we strive to make our software the industry standard,” explained Etiometry’s COO Evan Butler.
As the company continues to gain momentum as the industry leader in dynamic analytics for critical care, they’ve got a new focus for partners in 2019. Since earning FDA clearance on their first Risk Analytics Algorithm for neonates in 2016, the company has been committed to expanding this potentially life-saving software to a larger audience. According to Etiometry CTO Dr. Dimitar Baronov, “Rather than creating isolated algorithms to estimate adverse patient outcomes, Etiometry’s innovative technology allows the company to comprehensively and continuously track physiologic risks, which enables the care teams to avoid patient harm.” Etiometry’s T3 Software is cleared for patients of any age; however, the company’s current FDA clearance for the IDO2 Index allows use on patients ages 12 and under. Etiometry is in the process of obtaining FDA clearance for adult patients and is currently accepting research partnerships with academic medical centers specializing in adult medicine.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Leveraging AI in Learning Health Systems to improve patient outcomes, reduce costs
Published on DOTmed, by Etiometry’s CEO Shane Cooke It’s no secret that hospitals are facing some of their toughest challenges ever. Workforce shortages and burnout are commonplace and operating budgets are tight. Hospital leaders need to find increasingly creative ways to address these challenges and set themselves up for long-term success. Enter artificial intelligence (AI) technology. […]
HIMSS TV: Etiometry on AI’s role in clinical decision support
In this HIMSS TV interview, Etiometry CEO Shane Cooke dives into the transformative role of AI in clinical decision support—not as a replacement for clinicians, but as a powerful tool to enhance their expertise. Watch the full interview to see how he breaks down how predictive analytics can detect patient deterioration earlier, why AI-driven insights […]
Etiometry Achieves 10th FDA Clearance for Critical Care Platform
FDA Clearance Solidifies Etiometry’s Regulatory Leadership and Cybersecurity Excellence THURSDAY, FEB. 27, 2025- Boston, MA- As cybersecurity threats in healthcare continue to rise, and with the U.S. Food and Drug Administration (FDA) implementing stricter guidelines for cybersecurity compliance, Etiometry, the leader in clinical decision support software for high-acuity units, has received its 10th FDA clearance. This […]